Sun Pharma Advanced Research Company (SPARC) on Tuesday mentioned Dilip Shanghvi has resigned as managing director of the corporate.
Shanghvi expressed his want to step down and tendered his resignation because the MD with speedy impact, which was accepted by the board, SPARC mentioned in a regulatory submitting.
Shanghvi will, nonetheless, proceed to be related to the corporate’s board in his capability as a non-executive director and chairman, it added.
It additional said that the board, on the advice of Nomination and Remuneration Committee, has appointed Anil Raghavan as chief government officer (CEO) of the corporate with speedy impact for a time period of 5 years until May 24, 2026.
Prior to becoming a member of SPARC, Raghavan served because the managing director of the India and Sri Lanka enterprise of Quintiles, a worldwide pharmaceutical providers firm.
SPARC was shaped in 2007 by a demerger from drug main Sun Pharma.
